To address COVID-19 travel restrictions and prevent threat of COVID-19-related medical products, MEDISAFE is implementing webinars to strengthen capacity building in beneficiary countries in Eastern and Central Africa on substandard and falsified medicines (SFM) and medical products.
Starting in July 2020, MEDISAFE is organizing modules on how to better law enforcement capacity in terms of regulations of falsified and substandard medicines.
From July to September, trainees from Kenya, Rwanda, the Democratic Republic of the Congo and Malawi will benefit from webinars to share inter-agency information and develop a model legislation and regulations on SFM and medicinal products. The main objectives of these webinars are to train national experts to:
– analyze their respective national legislations using MEDICRIME Convention provisions
– identify the legal aspects which need to be modified or adapted at a national and/or regional levels
Other courses are planned on detection and identification of falsified and substandard medicines for MEDISAFE countries in order to keep operational capacities up-to-speed.
This e-learning support provided by MEDISAFE, will not replace on-site trainings and must be considered as an added value to gather more easily trainees from different agencies and geographical areas.
MEDISAFE is now considering how to provide tailor-made expertise in the specific context of COVID-19 for Burundi, the Democratic Republic of the Congo, Ethiopia, Ghana, Kenya, Malawi, Rwanda, Seychelles, Tanzania, Uganda and Zambia in the fight against SFM.